Literature DB >> 1679362

Inhibitory and excitatory effects of adenosine receptor agonists on evoked transmitter release from phrenic nerve ending of the rat.

P Correia-de-Sá1, A M Sebastião, J A Ribeiro.   

Abstract

1. The effects of the adenosine analogues, 5'-N-ethyl-carboxamide adenosine (NECA), R-N6-phenylisopropyladenosine (R-PIA), 2-chloroadenosine (CADO), and CGS 21680C on electrically evoked tritium outflow from preparations loaded with [3H]-choline and on evoked endplate potentials (e.p.ps), as well as the ability of the xanthines, 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) and PD 115,199 to antagonize the effects of the adenosine analogues, were investigated in phrenic nerve-diaphragm preparations. 2. NECA, R-PIA and CADO decreased, in a concentration-dependent manner, the evoked tritium outflow from preparations loaded with [3H]-choline. NECA and R-PIA were about equipotent and more potent than CADO. 3. DPCPX shifted to the right in a near parallel fashion the concentration-response curve for the inhibitory effect of R-PIA on evoked tritium outflow. 4. In the presence of DPCPX, NECA increased, rather than decreased, evoked tritium outflow. PD 115,119 antagonized, in a concentration-dependent manner, this excitatory effect of NECA. 5. CGS 21680C, in low nanomolar concentrations, increased evoked tritium outflow, an effect also antagonized by PD 115,119. 6. CGS 21680C increased, and R-PIA decreased, the amplitude of e.p.ps recorded from preparations paralysed with tubocurarine. Both effects could be observed in the same endplate. 7. It is concluded that both inhibitory (probably A1) and excitatory (probably A2) adenosine receptors coexist at the rat neuromuscular junction, modulating the evoked release of acetylcholine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1679362      PMCID: PMC1908352          DOI: 10.1111/j.1476-5381.1991.tb09836.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  8-Cyclopentyl-1,3-dipropylxanthine (DPCPX)--a selective high affinity antagonist radioligand for A1 adenosine receptors.

Authors:  M J Lohse; K N Klotz; J Lindenborn-Fotinos; M Reddington; U Schwabe; R A Olsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

2.  The effects of adenosine triphosphate and adenosine diphosphate on transmission at the rat and frog neuromuscular junctions.

Authors:  J A Ribeiro; J Walker
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

3.  An analysis of the end-plate potential recorded with an intracellular electrode.

Authors:  P FATT; B KATZ
Journal:  J Physiol       Date:  1951-11-28       Impact factor: 5.182

4.  The inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: antagonism by 1,3,8-substituted xanthines.

Authors:  A M Sebastião; T W Stone; J A Ribeiro
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

5.  The effect of adenosine on the release of the transmitter from the phrenic nerve of the rat.

Authors:  B L Ginsborg; G D Hirst
Journal:  J Physiol       Date:  1972-08       Impact factor: 5.182

6.  Both A1 and A2a purine receptors regulate striatal acetylcholine release.

Authors:  S J Brown; S James; M Reddington; P J Richardson
Journal:  J Neurochem       Date:  1990-07       Impact factor: 5.372

7.  Release of [3H]acetylcholine from a modified rat phrenic nerve-hemidiaphragm preparation.

Authors:  I Wessler; H Kilbinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-12       Impact factor: 3.000

8.  On the adenosine receptor and adenosine inactivation at the rat diaphragm neuromuscular junction.

Authors:  A M Sebastião; J A Ribeiro
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

9.  PD 115,199: an antagonist ligand for adenosine A2 receptors.

Authors:  R F Bruns; J H Fergus; E W Badger; J A Bristol; L A Santay; S J Hays
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-01       Impact factor: 3.000

10.  CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity.

Authors:  A J Hutchison; R L Webb; H H Oei; G R Ghai; M B Zimmerman; M Williams
Journal:  J Pharmacol Exp Ther       Date:  1989-10       Impact factor: 4.030

View more
  25 in total

1.  Ecto-AMP deaminase blunts the ATP-derived adenosine A2A receptor facilitation of acetylcholine release at rat motor nerve endings.

Authors:  M Teresa Magalhães-Cardoso; M Fátima Pereira; Laura Oliveira; J A Ribeiro; Rodrigo A Cunha; Paulo Correia-de-Sá
Journal:  J Physiol       Date:  2003-04-04       Impact factor: 5.182

2.  Adenosine A2B and A3 receptor location at the mouse neuromuscular junction.

Authors:  Neus Garcia; Mercedes Priego; Erica Hurtado; Teresa Obis; Manel M Santafe; Marta Tomàs; Maria Angel Lanuza; Josep Tomàs
Journal:  J Anat       Date:  2014-04-23       Impact factor: 2.610

3.  Preferential activation of excitatory adenosine receptors at rat hippocampal and neuromuscular synapses by adenosine formed from released adenine nucleotides.

Authors:  R A Cunha; P Correia-de-Sá; A M Sebastião; J A Ribeiro
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

4.  Evidence that the presynaptic A2a-adenosine receptor of the rat motor nerve endings is positively coupled to adenylate cyclase.

Authors:  P Correia-de-Sá; J A Ribeiro
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

5.  Adenosine receptor-mediated modulation of acetylcholine release from rat striatal synaptosomes.

Authors:  K A Kirkpatrick; P J Richardson
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

6.  Evidence for a cooperation between adenosine A2 receptors and beta 1-adrenoceptors on cardiac automaticity in the isolated right ventricle of the rat.

Authors:  J Hernandez; F Pinto; M A Figueira; J A Riberio
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

7.  Anxiolytic activity of adenosine receptor activation in mice.

Authors:  N Jain; N Kemp; O Adeyemo; P Buchanan; T W Stone
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

8.  Skeletal muscle expresses the extracellular cyclic AMP-adenosine pathway.

Authors:  T Chiavegatti; V L Costa; M S Araújo; R O Godinho
Journal:  Br J Pharmacol       Date:  2007-12-24       Impact factor: 8.739

9.  Tuning and fine-tuning of synapses with adenosine.

Authors:  A M Sebastião; J A Ribeiro
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

10.  Presymptomatic and symptomatic ALS SOD1(G93A) mice differ in adenosine A1 and A2A receptor-mediated tonic modulation of neuromuscular transmission.

Authors:  Filipe Nascimento; Ana M Sebastião; Joaquim A Ribeiro
Journal:  Purinergic Signal       Date:  2015-09-03       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.